Xenetic Biosciences (XBIO) Times Interest Earned (2011 - 2026)
Xenetic Biosciences' (XBIO) quarterly Times Interest Earned came in at -$0.01 in Q1 2026, up 44.72% YoY from -$0.01 in Q1 2025, and up 3.67% on a QoQ basis from -$0.01 in Q3 2025.
Xenetic Biosciences (XBIO) Times Interest Earned (2011 - 2026) Analysis & Trends
Xenetic Biosciences (XBIO) has 16 years of Times Interest Earned data on file, last reported at -$0.01 in Q1 2026.
- Quarterly Times Interest Earned rose 44.72% year-over-year to -$0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.06 (up 35.95% YoY) and the FY2025 annual result came in at -$0.07, up 30.33% from the prior year.
- Times Interest Earned climbed to -$0.01 in Q1 2026, from -$0.01 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.01 in Q3 2024 to a low of -$57.81 in Q4 2022.
- A 5-year average of -$4.16 and a median of -$0.03 in 2022 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 71.36% in 2022, down 120.75% in 2022.
- Tracing XBIO's Times Interest Earned over 5 years: stood at -$57.81 in 2022, then surged by 99.95% to -$0.03 in 2023, then surged by 57.94% to -$0.01 in 2024, then retreated by 6.18% to -$0.01 in 2025, then advanced by 3.67% to -$0.01 in 2026.
- The last three Times Interest Earned figures came in at -$0.01 (Q1 2026), -$0.01 (Q3 2025), and -$0.02 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02 |
| Mar 31, 2026 | -0.01 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.02 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.03 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -57.81 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.08 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -201.88 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -0.04 |
| Mar 31, 2021 | -0.05 |
| Dec 31, 2020 | -43.45 |